Public trial registry of the CCC-Munich

Trial Bolero-2

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Bolero-2
World
Full title
:

A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination with Exemestane in the Treatment of Postmenopausal Women with Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer who are refractory to Letrozole or Anastrozole

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C50.- Bösartige Neubildung der Brustdrüse [Mamma]
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants
Function Prename Surname Organization
World Responsible contact Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Principal Investigator Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Sponsor Novartis Magnifier